Marinomed receives EUR6m through final tranche of EIB financing agreement
Marinomed Biotech AG (VSE:MARI), an Austrian science-based biotech company with globally marketed therapeutics derived from proprietary technology platforms, has received the final EUR6 million tranche of its financing agreement with the European Investment Bank (EIB). The agreement originally was signed in February 2019 for a total of EUR15 million. The